Medicover Genetics is a leading innovator in genetic diagnostics and laboratory enablement with over 25 years of experience. The company provides advanced genetic testing services, genetic counselling, and certified diagnostic products. Its proprietary Technology Transfer Platform enables laboratories worldwide to perform high-precision genetic tests in-house. The CE-marked, IVDR-certified portfolio includes VERACITY™ NIPT and TarCET™ assays, addressing diverse clinical needs across the patient journey. With CAP- and ISO-accredited laboratories and a presence across Europe, Asia, and Africa, Medicover Genetics supports scalable genomic solutions for personalized medicine. Part of Medicover, listed on Nasdaq Stockholm.
